1. RLMD
80.86% increase in pro-forma market cap
https://finance.yahoo.com/quote/RLMD?p=RLMD
RLMD big move up on October 15
https://seekingalpha.com/news/35057...s-1017-data-in-treatment-resistant-depression
closed at $24.95 on Monday November 18.
Went up for 10 straight sessions, to close at $34.46 on Tuesday December 3.
Market cap as at December 3:
10,383,417 * $34.46 = $357.812 million
PR at 4.10pm that day:
"Relmada Therapeutics Announces Proposed Public Offering of Common Stock "
https://www.prnewswire.com/news-rel...ublic-offering-of-common-stock-300968644.html
Pricing announced less than 7 hours later:
"Relmada Therapeutics Announces Pricing of Public Offering of Common Stock "
https://www.prnewswire.com/news-rel...ublic-offering-of-common-stock-300968842.html
3,333,334 shares @ $30.
30-day option to sell another 500,000 shares at $30.
Offering expected to close on Friday December 6.
Prospectus supplement
https://www.sec.gov/Archives/edgar/data/1553643/000121390019025209/f424b5120219_relmadathera.htm
10,383,417 shares of our common stock outstanding as of December 2, 2019
Stock opened near the intraday low at $38.22, closed 36.91% higher at $47.18
New share count including the new shares:
10,383,417 + 3,333,334 = 13,716,751
at share price of $47.18
pro-forma market cap as at December 4 was $647.156 million
market cap as at December 3 was 10,383,417 * $34.46 = $357.812 million
(pro-forma) market cap increase in one day: 80.86%
.